Technology | May 21, 2018

Innovative Health Receives FDA Clearance to Reprocess the ViewFlex Xtra Diagnostic Ultrasound Catheter

Company reprocesses devices with more complex technology, addressing the unmet need

The Abbott ViewFlex Xtra Diagnostic Ultrasound Catheter now can be reprocessed by Innovative Health.

May 21, 2018 — Cardiology medical device reprocessing company Innovative Health recently received U.S. Food and Drug Administration (FDA) clearance to reprocess the Abbott ViewFlex Xtra Diagnostic Ultrasound Catheter. Ultimately, this clearance will allow the company to develop a full product suite for clinicians based on this new category of devices, including other widely used mapping and imaging catheters.

The company said it launched this product reprocessing effort based on direct feedback from its customers, including clinicians in the electrophysiology (EP) field.The device is much more complex to reprocess than many types of catheters, which required the FDA clearance. 

Innovative Health continues to make extensive investments in research and development, enabling the company to pursue clearances for devices which are based on the very latest, difficult-to-reprocess technologies. In the last two years, the company has received three times more EP FDA clearances than all of its competitors combined. Reprocessors must actively pursue FDA clearances in order to introduce new products, which involves documenting that they can achieve levels of quality and safety comparable to those of the original device. This research can also help companies like Innovative Health identify entirely new reprocessing approaches, as it has with the ViewFlex catheter, allowing them to more easily pursue clearances for other new products based on similar technologies.

The ViewFlex catheter is used frequently in EP labs today to help visualize cardiac anatomy and physiology. With this recent FDA clearance, it will be added to Innovative Health’s vast portfolio of reprocessed devices include diagnostic, ultrasound and mapping catheters, as well as other EP-specific devices. Innovative Health partners with hospitals to collect the devices, then applies a rigorous, proprietary process to clean, test and sterilize them for re-use. As a result, the company claims it can help hospitals save hundreds of thousands of dollars on medical device spending per year, all while maintaining patient safety.

For more information: innovative-health.com

 

Related Content

Lenox Hill Hospital Opens New Heart Rhythm Center
News | EP Lab | August 27, 2019
Lenox Hill Hospital (New York, N.Y.) has established a brand new Heart Rhythm Center dedicated to the treatment of...
Damaged Hearts Rewired With Nanotube Fibers

Researchers at Texas Heart Institute and Rice University have confirmed that flexible, conductive fibers made of carbon nanotubes can bridge damaged tissue to deliver electrical signals and keep hearts beating despite congestive heart failure or dilated cardiomyopathy or after a heart attack. Image courtesy of Texas Heart Institute.

News | EP Lab | August 15, 2019
Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart tissues and deliver the...
Cardiac Device Complications Vary Widely Among Hospitals
News | EP Lab | July 31, 2019
The chances of patients experiencing complications after having a cardiac device implanted vary according to where they...
A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The new scoring system was presented as a follow up to that study during a late-breaking session at Heart Rhythm 2019, the Heart Rhythm Society's 40th Annual Scientific Sessions.

Figure 1: The PADIT infection risk score ranging from 0 to 14 points classified patients into three risk groups, low (0-4), intermediate (5-6) and high (≥7). The risk groups had rates of hospitalization for infection of 0.51%, 1.42% and 3.41%, respectively 

News | EP Lab | May 15, 2019
May 15, 2019 — A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] Th
Studies Find Race and Gender Disparities in Implantable Heart Devices
News | EP Lab | May 15, 2019
May 15, 2019 - Three new studies show that patients who are medically indicated for implantable heart devices, includ
Heart Rhythm 2019 study shows travelers with common cardiac devices can pass through without restrictions or precautions. HRS 2019, #HRS #HRS19

A new study shows travelers with common cardiac devices can pass through airport body scanners without restrictions or precautions.

News | EP Lab | May 14, 2019
May 14, 2019 – Results from new research show that passengers with cardiac implantable electronic devices (CIEDs), su
News | EP Lab | May 13, 2019
May 13, 2019 – Results from a new survey are the first to report a large discrepancy in patient’s knowledge of their
Concerto CRT-D and Virtuoso ICD implantable cardiac devices are among several Medtronic electrophysiology devices included in a safety alert because of their lack of cybersecurity measures to avoid hacking, according to the FDA.

Concerto CRT-D and Virtuoso ICD implantable cardiac devices are among several Medtronic electrophysiology devices included in a safety alert because of their lack of cybersecurity measures to avoid hacking, according to the FDA.

Feature | EP Lab | March 22, 2019
March 22, 2019 — The U.S.
Overlay Init